A collaborative team led by Professor Zeng-Bing Chen from Nanjing University and Associate Professor Hua-Lei Yin from Renmin University of China has experimentally demonstrated an efficient multiuser source-independent (SI) QCKA protocol based on Bell state distribution.

To investigate the role of KIF13B in SICD, a research team led by Prof. Xunde Xian from Peking University conducted a series of experiments using mouse models of sepsis and cultured cardiomyocytes.

This study represents the first report of loading TIG onto hemoglobin (HB) nanoparticles. This system utilizes the iron dependence of K. pneumoniae to enhance the targeting ability of TIG and increase the drug concentration at the infection site, thereby enhancing the antibacterial activity and providing a promising strategy for combating drug-resistant gram-negative bacterial pneumonia.

Impaired mitophagy and the accumulation of damaged mitochondria are key drivers of endothelial cell (EC) dysfunction in diabetic wounds. While mitochondrial transplantation (MT) has demonstrated therapeuticpotential in such mitochondrial damage-related diseases, its application is still thwarted by elusive mechanisms and practical hurdles such as poor targeting specificity and low delivery efficiency. Here, wereveal that MT acts by reactivating mitophagy to selectively eliminate dysfunctional mitochondria, therebyrestoring mitochondrial homeostasis and rescuing EC functionality. To exploit this discovery, we engineer abiomimetic MT strategy through coating EC-derived apoptotic vesicle membrane (AVM) onto the surfaceof isolated mitochondria. The resulting mitochondria–AVM complex (Mito-AVM) leverages homologoustargeting and phosphatidylserine-mediated “eat-me” signaling, achieving a remarkable 150% increasein delivery efficiency to ECs in diabetic wounds. Furthermore, we construct a 3-aminophenylboric acid-modified hyaluronic acid/polyvinyl alcohol hydrogel for the diabetic wound microenvironment, enablingreactive oxygen species/glucose-triggered sustained release of encapsulated Mito-AVM at the wound site. In summary, our work elucidates a fundamental mechanism of MT and provides an efficient and targetedstrategy for MT therapy, offering fresh perspectives for diabetic wound treatment.

The research findings have been published in Research under the title "Apoptotic Vesicle Membrane-Mediated Targeted Endothelial Mitochondrial Transplantation-Clearance Therapy for Diabetic Wound Healing."